Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Journal of Experimental & Clinical Cancer Research : CR|November 29, 2019
MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathwayJian-Hui Li, Xiao-Xu Zhu, Fu-Xi Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 11, 2020
Targeting Super-Enhancers via Nanoparticle-Facilitated BRD4 and CDK7 Inhibitors Synergistically Suppresses Pancreatic Ductal AdenocarcinomaChen-Song Huang, Xinru You, Chunlei Dai, et al.
Nanoscale|July 31, 2020
Histone methyltransferase G9a inhibitor-loaded redox-responsive nanoparticles for pancreatic ductal adenocarcinoma therapyJie-Qin Wang, Li-Ying Wang, Shi-Jin Li, et al.
Oncogene|June 24, 2024
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistanceMing-Jian Ma, Yin-Hao Shi, Zhi-De Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 3, 2024
Epigenetic Activation of the CMTM6-IGF2BP1-EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal AdenocarcinomaYing-Qin Zhu, Yue Huang, Yin-Hao Shi, et al.
Cancer Letters|January 30, 2024
CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagyZhi-De Liu, Yin-Hao Shi, Qiong-Cong Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 3, 2024
Platelet-Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP1 Mediated Lipid MetabolismYin-Hao Shi, Zhi-De Liu, Ming-Jian Ma, et al.
Pageof 5